2023-2029 Global Non-24-hour Sleep-wake Disorder Treatment Industry Research & Trends Analysis Report
2023-2029 Global Non-24-hour Sleep-wake Disorder Treatment Industry Research & Trends Analysis Report
Discover the latest insights into the booming Non-24-hour Sleep-wake Disorder Treatment Market. This report analyzes market size, growth trends (CAGR ), key players, and regional performance, offering valuable data for investors and industry professionals. Explore market drivers, restraints, and future projections for -.
Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!
According to the Latest Research Report,, the global market for Non-24-hour Sleep-wake Disorder Treatment should grow from US$ 480 million in 2022 to US$ 726.1 million by 2029, with a CAGR of 6.1% for the period of 2023-2029.
China Non-24-hour Sleep-wake Disorder Treatment market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
The United States Non-24-hour Sleep-wake Disorder Treatment market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
In terms of type, Prescription Drugs segment holds a share about % in 2022 and will reach % in 2029; while in terms of application, Hospital Pharmacies has a share approximately % in 2022 and will grow at a CAGR % during 2023 and 2029.
The global key manufacturers of Non-24-hour Sleep-wake Disorder Treatment include Teva, Mylan, Nature’s Bounty, Otsuka Pharma (Pharmavite), Boiron, Miers Laboratories, Genexa, Homeocan and Clinigen Group, etc. In 2022, the global top five players hold a share approximately % in terms of revenue.
Non-24-hour sleep-wake disorder (N24) is a circadian rhythm sleep disorder in which an individual's biological clock fails to synchronize to a 24-hour day. Instead of sleeping at roughly the same time every day, someone with N24 will typically find their sleep time gradually delaying by minutes to hours every day.
This report aims to provide a comprehensive study of the global market for Non-24-hour Sleep-wake Disorder Treatment.
Key Highlights of the Report
(1) Global Non-24-hour Sleep-wake Disorder Treatment market size (value), history data from 2018-2022 and forecast data from 2023 to 2029.
(2) Global Non-24-hour Sleep-wake Disorder Treatment market competitive situation, revenue and market share, from 2018 to 2022.
(3) China Non-24-hour Sleep-wake Disorder Treatment market competitive situation, revenue and market share, from 2018 to 2022.
(4) Global Non-24-hour Sleep-wake Disorder Treatment segment by region (or country), key regions cover the United States, Europe, Japan, South Korea, Southeast Asia and India, etc.
(5) Global Non-24-hour Sleep-wake Disorder Treatment segment by type and by application and regional segment by type and by application.
(6) Non-24-hour Sleep-wake Disorder Treatment industry supply chain, upstream, midstream and downstream analysis.
Key Regions Covered in This Report Are:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Market segment by type, covers
Prescription Drugs
OTC
Market segment by application, can be divided into
Hospital Pharmacies
Retail Pharmacies
Other
Market segment by players, this report covers
Teva
Mylan
Nature’s Bounty
Otsuka Pharma (Pharmavite)
Boiron
Miers Laboratories
Genexa
Homeocan
Clinigen Group
Vanda Pharma
1 Market Overview
1.1 Product Overview and Scope of Non-24-hour Sleep-wake Disorder Treatment
1.2 Global Non-24-hour Sleep-wake Disorder Treatment Market Size and Forecast
1.3 China Non-24-hour Sleep-wake Disorder Treatment Market Size and Forecast
1.4 China Market Percentage in Global
1.4.1 By Revenue, China Non-24-hour Sleep-wake Disorder Treatment Share in Global Market, 2018-2029
1.4.2 Non-24-hour Sleep-wake Disorder Treatment Market Size: China VS Global, 2018-2029
1.5 Non-24-hour Sleep-wake Disorder Treatment Market Dynamics
1.5.1 Non-24-hour Sleep-wake Disorder Treatment Market Drivers
1.5.2 Non-24-hour Sleep-wake Disorder Treatment Market Restraints
1.5.3 Non-24-hour Sleep-wake Disorder Treatment Industry Trends
1.5.4 Non-24-hour Sleep-wake Disorder Treatment Industry Policy
2 Global Competitive Situation by Company
2.1 Global Non-24-hour Sleep-wake Disorder Treatment Revenue by Company (2018-2023)
2.2 Global Non-24-hour Sleep-wake Disorder Treatment Participants, Market Position (Tier 1, Tier 2 and Tier 3)
2.3 Global Non-24-hour Sleep-wake Disorder Treatment Concentration Ratio
2.4 Global Non-24-hour Sleep-wake Disorder Treatment Mergers & Acquisitions, Expansion Plans
2.5 Global Non-24-hour Sleep-wake Disorder Treatment Manufacturers Product Type
3 China Competitive Situation by Company
3.1 China Non-24-hour Sleep-wake Disorder Treatment Revenue by Company (2018-2023)
3.2 China Non-24-hour Sleep-wake Disorder Treatment Non-24-hour Sleep-wake Disorder Treatment Participants, Market Position (Tier 1, Tier 2 and Tier 3)
3.3 China Non-24-hour Sleep-wake Disorder Treatment, Revenue Percentage of Local Players VS Foreign Manufacturers (2018-2023)
4 Industry Chain Analysis
4.1 Non-24-hour Sleep-wake Disorder Treatment Industry Chain
4.2 Non-24-hour Sleep-wake Disorder Treatment Upstream Analysis
4.3 Non-24-hour Sleep-wake Disorder Treatment Midstream Analysis
4.4 Non-24-hour Sleep-wake Disorder Treatment Downstream Analysis
5 Sights by Type
5.1 Non-24-hour Sleep-wake Disorder Treatment Classification
5.1.1 Prescription Drugs
5.1.2 OTC
5.2 By Type, Global Non-24-hour Sleep-wake Disorder Treatment Market Size & CAGR, 2018 VS 2022 VS 2029
5.3 By Type, Global Non-24-hour Sleep-wake Disorder Treatment Revenue, 2018-2029
6 Sights by Application
6.1 Non-24-hour Sleep-wake Disorder Treatment Segment by Application
6.1.1 Hospital Pharmacies
6.1.2 Retail Pharmacies
6.1.3 Other
6.2 By Application, Global Non-24-hour Sleep-wake Disorder Treatment Market Size & CAGR, 2018 VS 2022 VS 2029
6.3 By Application, Global Non-24-hour Sleep-wake Disorder Treatment Revenue, 2018-2029
7 Sales Sights by Region
7.1 By Region, Global Non-24-hour Sleep-wake Disorder Treatment Market Size, 2018 VS 2022 VS 2029
7.2 By Region, Global Non-24-hour Sleep-wake Disorder Treatment Market Size, 2018-2029
7.3 North America
7.3.1 North America Non-24-hour Sleep-wake Disorder Treatment Market Size & Forecasts, 2018-2029
7.3.2 By Country, North America Non-24-hour Sleep-wake Disorder Treatment Market Size Market Share
7.4 Europe
7.4.1 Europe Non-24-hour Sleep-wake Disorder Treatment Market Size & Forecasts, 2018-2029
7.4.2 By Country, Europe Non-24-hour Sleep-wake Disorder Treatment Market Size Market Share
7.5 Asia Pacific
7.5.1 Asia Pacific Non-24-hour Sleep-wake Disorder Treatment Market Size & Forecasts, 2018-2029
7.5.2 By Country/Region, Asia Pacific Non-24-hour Sleep-wake Disorder Treatment Market Size Market Share
7.6 South America
7.6.1 South America Non-24-hour Sleep-wake Disorder Treatment Market Size & Forecasts, 2018-2029
7.6.2 By Country, South America Non-24-hour Sleep-wake Disorder Treatment Market Size Market Share
7.7 Middle East & Africa
8 Sights by Country Level
8.1 By Country, Global Non-24-hour Sleep-wake Disorder Treatment Market Size & CAGR，2018 VS 2022 VS 2029
8.2 By Country, Global Non-24-hour Sleep-wake Disorder Treatment Market Size, 2018-2029
8.3 U.S.
8.3.1 U.S. Non-24-hour Sleep-wake Disorder Treatment Market Size, 2018-2029
8.3.2 By Company, U.S. Non-24-hour Sleep-wake Disorder Treatment Revenue Market Share, 2018-2023
8.3.3 By Type, U.S. Non-24-hour Sleep-wake Disorder Treatment Revenue Market Share, 2022 VS 2029
8.3.4 By Application, U.S. Non-24-hour Sleep-wake Disorder Treatment Revenue Market Share, 2022 VS 2029
8.4 Europe
8.4.1 Europe Non-24-hour Sleep-wake Disorder Treatment Market Size, 2018-2029
8.4.2 By Company, Europe Non-24-hour Sleep-wake Disorder Treatment Revenue Market Share, 2018-2023
8.4.3 By Type, Europe Non-24-hour Sleep-wake Disorder Treatment Revenue Market Share, 2022 VS 2029
8.4.4 By Application, Europe Non-24-hour Sleep-wake Disorder Treatment Revenue Market Share, 2022 VS 2029
8.5 China
8.5.1 China Non-24-hour Sleep-wake Disorder Treatment Market Size, 2018-2029
8.5.2 By Company, China Non-24-hour Sleep-wake Disorder Treatment Revenue Market Share, 2018-2023
8.5.3 By Type, China Non-24-hour Sleep-wake Disorder Treatment Revenue Market Share, 2022 VS 2029
8.5.4 By Application, China Non-24-hour Sleep-wake Disorder Treatment Revenue Market Share, 2022 VS 2029
8.6 Japan
8.6.1 Japan Non-24-hour Sleep-wake Disorder Treatment Market Size, 2018-2029
8.6.2 By Company, Japan Non-24-hour Sleep-wake Disorder Treatment Revenue Market Share, 2018-2023
8.6.3 By Type, Japan Non-24-hour Sleep-wake Disorder Treatment Revenue Market Share, 2022 VS 2029
8.6.4 By Application, Japan Non-24-hour Sleep-wake Disorder Treatment Revenue Market Share, 2022 VS 2029
8.7 South Korea
8.7.1 South Korea Non-24-hour Sleep-wake Disorder Treatment Market Size, 2018-2029
8.7.2 By Company, South Korea Non-24-hour Sleep-wake Disorder Treatment Revenue Market Share, 2018-2023
8.7.3 By Type, South Korea Non-24-hour Sleep-wake Disorder Treatment Revenue Market Share, 2022 VS 2029
8.7.4 By Application, South Korea Non-24-hour Sleep-wake Disorder Treatment Revenue Market Share, 2022 VS 2029
8.8 Southeast Asia
8.8.1 Southeast Asia Non-24-hour Sleep-wake Disorder Treatment Market Size, 2018-2029
8.8.2 By Company, Southeast Asia Non-24-hour Sleep-wake Disorder Treatment Revenue Market Share, 2018-2023
8.8.3 By Type, Southeast Asia Non-24-hour Sleep-wake Disorder Treatment Revenue Market Share, 2022 VS 2029
8.8.4 By Application, Southeast Asia Non-24-hour Sleep-wake Disorder Treatment Revenue Market Share, 2022 VS 2029
8.9 India
8.9.1 India Non-24-hour Sleep-wake Disorder Treatment Market Size, 2018-2029
8.9.2 By Company, India Non-24-hour Sleep-wake Disorder Treatment Revenue Market Share, 2018-2023
8.9.3 By Type, India Non-24-hour Sleep-wake Disorder Treatment Revenue Market Share, 2022 VS 2029
8.9.4 By Application, India Non-24-hour Sleep-wake Disorder Treatment Revenue Market Share, 2022 VS 2029
8.10 Middle East & Asia
8.10.1 Middle East & Asia Non-24-hour Sleep-wake Disorder Treatment Market Size, 2018-2029
8.10.2 By Company, Middle East & Asia Non-24-hour Sleep-wake Disorder Treatment Revenue Market Share, 2018-2023
8.10.3 By Type, Middle East & Asia Non-24-hour Sleep-wake Disorder Treatment Revenue Market Share, 2022 VS 2029
8.10.4 By Application, Middle East & Asia Non-24-hour Sleep-wake Disorder Treatment Revenue Market Share, 2022 VS 2029
9 Global Manufacturers Profile
9.1 Teva
9.1.1 Teva Company Information, Head Office, Market Area and Industry Position
9.1.2 Teva Company Profile and Main Business
9.1.3 Teva Non-24-hour Sleep-wake Disorder Treatment Models, Specifications and Application
9.1.4 Teva Non-24-hour Sleep-wake Disorder Treatment Revenue and Gross Margin, 2018-2023
9.1.5 Teva Recent Developments
9.2 Mylan
9.2.1 Mylan Company Information, Head Office, Market Area and Industry Position
9.2.2 Mylan Company Profile and Main Business
9.2.3 Mylan Non-24-hour Sleep-wake Disorder Treatment Models, Specifications and Application
9.2.4 Mylan Non-24-hour Sleep-wake Disorder Treatment Revenue and Gross Margin, 2018-2023
9.2.5 Mylan Recent Developments
9.3 Nature’s Bounty
9.3.1 Nature’s Bounty Company Information, Head Office, Market Area and Industry Position
9.3.2 Nature’s Bounty Company Profile and Main Business
9.3.3 Nature’s Bounty Non-24-hour Sleep-wake Disorder Treatment Models, Specifications and Application
9.3.4 Nature’s Bounty Non-24-hour Sleep-wake Disorder Treatment Revenue and Gross Margin, 2018-2023
9.3.5 Nature’s Bounty Recent Developments
9.4 Otsuka Pharma (Pharmavite)
9.4.1 Otsuka Pharma (Pharmavite) Company Information, Head Office, Market Area and Industry Position
9.4.2 Otsuka Pharma (Pharmavite) Company Profile and Main Business
9.4.3 Otsuka Pharma (Pharmavite) Non-24-hour Sleep-wake Disorder Treatment Models, Specifications and Application
9.4.4 Otsuka Pharma (Pharmavite) Non-24-hour Sleep-wake Disorder Treatment Revenue and Gross Margin, 2018-2023
9.4.5 Otsuka Pharma (Pharmavite) Recent Developments
9.5 Boiron
9.5.1 Boiron Company Information, Head Office, Market Area and Industry Position
9.5.2 Boiron Company Profile and Main Business
9.5.3 Boiron Non-24-hour Sleep-wake Disorder Treatment Models, Specifications and Application
9.5.4 Boiron Non-24-hour Sleep-wake Disorder Treatment Revenue and Gross Margin, 2018-2023
9.5.5 Boiron Recent Developments
9.6 Miers Laboratories
9.6.1 Miers Laboratories Company Information, Head Office, Market Area and Industry Position
9.6.2 Miers Laboratories Company Profile and Main Business
9.6.3 Miers Laboratories Non-24-hour Sleep-wake Disorder Treatment Models, Specifications and Application
9.6.4 Miers Laboratories Non-24-hour Sleep-wake Disorder Treatment Revenue and Gross Margin, 2018-2023
9.6.5 Miers Laboratories Recent Developments
9.7 Genexa
9.7.1 Genexa Company Information, Head Office, Market Area and Industry Position
9.7.2 Genexa Company Profile and Main Business
9.7.3 Genexa Non-24-hour Sleep-wake Disorder Treatment Models, Specifications and Application
9.7.4 Genexa Non-24-hour Sleep-wake Disorder Treatment Revenue and Gross Margin, 2018-2023
9.7.5 Genexa Recent Developments
9.8 Homeocan
9.8.1 Homeocan Company Information, Head Office, Market Area and Industry Position
9.8.2 Homeocan Company Profile and Main Business
9.8.3 Homeocan Non-24-hour Sleep-wake Disorder Treatment Models, Specifications and Application
9.8.4 Homeocan Non-24-hour Sleep-wake Disorder Treatment Revenue and Gross Margin, 2018-2023
9.8.5 Homeocan Recent Developments
9.9 Clinigen Group
9.9.1 Clinigen Group Company Information, Head Office, Market Area and Industry Position
9.9.2 Clinigen Group Company Profile and Main Business
9.9.3 Clinigen Group Non-24-hour Sleep-wake Disorder Treatment Models, Specifications and Application
9.9.4 Clinigen Group Non-24-hour Sleep-wake Disorder Treatment Revenue and Gross Margin, 2018-2023
9.9.5 Clinigen Group Recent Developments
9.10 Vanda Pharma
9.10.1 Vanda Pharma Company Information, Head Office, Market Area and Industry Position
9.10.2 Vanda Pharma Company Profile and Main Business
9.10.3 Vanda Pharma Non-24-hour Sleep-wake Disorder Treatment Models, Specifications and Application
9.10.4 Vanda Pharma Non-24-hour Sleep-wake Disorder Treatment Revenue and Gross Margin, 2018-2023
9.10.5 Vanda Pharma Recent Developments
10 Conclusion
11 Appendix
11.1 Research Methodology
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Market Estimation Model
11.4 Disclaimer
Tables & Figures:
Table 1. Non-24-hour Sleep-wake Disorder Treatment Market Size & CAGR: China VS Global, (US$ Million), 2018-2029
Table 2. Non-24-hour Sleep-wake Disorder Treatment Market Restraints
Table 3. Non-24-hour Sleep-wake Disorder Treatment Market Trends
Table 4. Non-24-hour Sleep-wake Disorder Treatment Industry Policy
Table 5. Global Non-24-hour Sleep-wake Disorder Treatment Revenue by Company (2018-2023) & (US$ million)
Table 6. Global Non-24-hour Sleep-wake Disorder Treatment Revenue Market Share by Company (2018-2023)
Table 7. Global Non-24-hour Sleep-wake Disorder Treatment Manufacturers Market Concentration Ratio (CR3 and HHI)
Table 8. Global Non-24-hour Sleep-wake Disorder Treatment Mergers & Acquisitions, Expansion Plans
Table 9. Global Non-24-hour Sleep-wake Disorder Treatment Manufacturers Product Type
Table 10. China Non-24-hour Sleep-wake Disorder Treatment Revenue by Company (2018-2023) & (US$ million)
Table 11. China Non-24-hour Sleep-wake Disorder Treatment Revenue Market Share by Company (2018-2023)
Table 12. Global Key Players of Non-24-hour Sleep-wake Disorder Treatment Upstream (Raw Materials)
Table 13. Global Non-24-hour Sleep-wake Disorder Treatment Typical Customers
Table 14. Non-24-hour Sleep-wake Disorder Treatment Typical Distributors
Table 15. By Type, Global Non-24-hour Sleep-wake Disorder Treatment Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 16. By Application, Global Non-24-hour Sleep-wake Disorder Treatment Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 17. By Region, Global Non-24-hour Sleep-wake Disorder Treatment Market Size, 2018 VS 2022 VS 2029, US$ Million
Table 18. By Region, Global Non-24-hour Sleep-wake Disorder Treatment Revenue, 2018-2029, US$ Million
Table 19. By Country, Global Non-24-hour Sleep-wake Disorder Treatment Revenue & CAGR，2018 VS 2022 VS 2029, US$ Million
Table 20. By Country, Global Non-24-hour Sleep-wake Disorder Treatment Revenue, 2018-2029, US$ Million
Table 21. By Country, Global Non-24-hour Sleep-wake Disorder Treatment Revenue Market Share, 2018-2029
Table 22. Teva Company Information, Head Office, Market Area and Industry Position
Table 23. Teva Company Profile and Main Business
Table 24. Teva Non-24-hour Sleep-wake Disorder Treatment Models, Specifications and Application
Table 25. Teva Non-24-hour Sleep-wake Disorder Treatment Revenue and Gross Margin, 2018-2023
Table 26. Teva Recent Developments
Table 27. Mylan Company Information, Head Office, Market Area and Industry Position
Table 28. Mylan Company Profile and Main Business
Table 29. Mylan Non-24-hour Sleep-wake Disorder Treatment Models, Specifications and Application
Table 30. Mylan Non-24-hour Sleep-wake Disorder Treatment Revenue and Gross Margin, 2018-2023
Table 31. Mylan Recent Developments
Table 32. Nature’s Bounty Company Information, Head Office, Market Area and Industry Position
Table 33. Nature’s Bounty Company Profile and Main Business
Table 34. Nature’s Bounty Non-24-hour Sleep-wake Disorder Treatment Models, Specifications and Application
Table 35. Nature’s Bounty Non-24-hour Sleep-wake Disorder Treatment Revenue and Gross Margin, 2018-2023
Table 36. Nature’s Bounty Recent Developments
Table 37. Otsuka Pharma (Pharmavite) Company Information, Head Office, Market Area and Industry Position
Table 38. Otsuka Pharma (Pharmavite) Company Profile and Main Business
Table 39. Otsuka Pharma (Pharmavite) Non-24-hour Sleep-wake Disorder Treatment Models, Specifications and Application
Table 40. Otsuka Pharma (Pharmavite) Non-24-hour Sleep-wake Disorder Treatment Revenue and Gross Margin, 2018-2023
Table 41. Otsuka Pharma (Pharmavite) Recent Developments
Table 42. Boiron Company Information, Head Office, Market Area and Industry Position
Table 43. Boiron Company Profile and Main Business
Table 44. Boiron Non-24-hour Sleep-wake Disorder Treatment Models, Specifications and Application
Table 45. Boiron Non-24-hour Sleep-wake Disorder Treatment Revenue and Gross Margin, 2018-2023
Table 46. Boiron Recent Developments
Table 47. Miers Laboratories Company Information, Head Office, Market Area and Industry Position
Table 48. Miers Laboratories Company Profile and Main Business
Table 49. Miers Laboratories Non-24-hour Sleep-wake Disorder Treatment Models, Specifications and Application
Table 50. Miers Laboratories Non-24-hour Sleep-wake Disorder Treatment Revenue and Gross Margin, 2018-2023
Table 51. Miers Laboratories Recent Developments
Table 52. Genexa Company Information, Head Office, Market Area and Industry Position
Table 53. Genexa Company Profile and Main Business
Table 54. Genexa Non-24-hour Sleep-wake Disorder Treatment Models, Specifications and Application
Table 55. Genexa Non-24-hour Sleep-wake Disorder Treatment Revenue and Gross Margin, 2018-2023
Table 56. Genexa Recent Developments
Table 57. Homeocan Company Information, Head Office, Market Area and Industry Position
Table 58. Homeocan Company Profile and Main Business
Table 59. Homeocan Non-24-hour Sleep-wake Disorder Treatment Models, Specifications and Application
Table 60. Homeocan Non-24-hour Sleep-wake Disorder Treatment Revenue and Gross Margin, 2018-2023
Table 61. Homeocan Recent Developments
Table 62. Clinigen Group Company Information, Head Office, Market Area and Industry Position
Table 63. Clinigen Group Company Profile and Main Business
Table 64. Clinigen Group Non-24-hour Sleep-wake Disorder Treatment Models, Specifications and Application
Table 65. Clinigen Group Non-24-hour Sleep-wake Disorder Treatment Revenue and Gross Margin, 2018-2023
Table 66. Clinigen Group Recent Developments
Table 67. Vanda Pharma Company Information, Head Office, Market Area and Industry Position
Table 68. Vanda Pharma Company Profile and Main Business
Table 69. Vanda Pharma Non-24-hour Sleep-wake Disorder Treatment Models, Specifications and Application
Table 70. Vanda Pharma Non-24-hour Sleep-wake Disorder Treatment Revenue and Gross Margin, 2018-2023
Table 71. Vanda Pharma Recent Developments
List of Figure
Figure 1. Non-24-hour Sleep-wake Disorder Treatment Picture
Figure 2. Global Non-24-hour Sleep-wake Disorder Treatment Industry Market Size and Forecast (US$ million) & (2018-2029)
Figure 3. China Non-24-hour Sleep-wake Disorder Treatment Revenue and Forecast (US$ million) & (2018-2029)
Figure 4. 2018-2029 China Non-24-hour Sleep-wake Disorder Treatment Market Share of Global
Figure 5. Global Non-24-hour Sleep-wake Disorder Treatment Key Participants, Market Share, 2021 VS 2022 VS 2023
Figure 6. Global Non-24-hour Sleep-wake Disorder Treatment Market Share by Company, (Tier 1, Tier 2 and Tier 3), 2018-2023
Figure 7. China Non-24-hour Sleep-wake Disorder Treatment Key Participants, Market Share, 2021 VS 2022 VS 2023
Figure 8. China Non-24-hour Sleep-wake Disorder Treatment Revenue, Domestic VS Import Products, Proportion of China Local Players and Foreign Players, 2018-2023
Figure 9. Non-24-hour Sleep-wake Disorder Treatment Industry Chain
Figure 10. Prescription Drugs
Figure 11. OTC
Figure 12. By Type, Global Non-24-hour Sleep-wake Disorder Treatment Revenue, 2018-2029, US$ Million
Figure 13. By Type, Global Non-24-hour Sleep-wake Disorder Treatment Revenue Market Share, 2018-2029
Figure 14. Hospital Pharmacies
Figure 15. Retail Pharmacies
Figure 16. Other
Figure 17. By Application, Global Non-24-hour Sleep-wake Disorder Treatment Revenue, 2018-2029, US$ Million
Figure 18. By Application, Global Non-24-hour Sleep-wake Disorder Treatment Revenue Market Share, 2018-2029
Figure 19. By Region, Global Non-24-hour Sleep-wake Disorder Treatment Revenue Market Share, 2018-2029
Figure 20. North America Non-24-hour Sleep-wake Disorder Treatment Revenue & Forecasts, 2018-2029, US$ Million
Figure 21. By Country, North America Non-24-hour Sleep-wake Disorder Treatment Revenue Market Share, 2018-2023
Figure 22. Europe Non-24-hour Sleep-wake Disorder Treatment Revenue & Forecasts, 2018-2029, US$ Million
Figure 23. By Country, Europe Non-24-hour Sleep-wake Disorder Treatment Revenue Market Share, 2018-2023
Figure 24. Asia Pacific Non-24-hour Sleep-wake Disorder Treatment Revenue & Forecasts, 2018-2029, US$ Million
Figure 25. By Country/Region, Asia Pacific Non-24-hour Sleep-wake Disorder Treatment Revenue Market Share, 2018-2023
Figure 26. South America Non-24-hour Sleep-wake Disorder Treatment Revenue & Forecasts, 2018-2029, US$ Million
Figure 27. By Country, South America Non-24-hour Sleep-wake Disorder Treatment Revenue Market Share, 2018-2023
Figure 28. Middle East & Africa Non-24-hour Sleep-wake Disorder Treatment Revenue & Forecasts, 2018-2029, US$ Million
Figure 29. U.S. Non-24-hour Sleep-wake Disorder Treatment Revenue, 2018-2029, (US$ Million)
Figure 30. By Company, U.S. Non-24-hour Sleep-wake Disorder Treatment Market Share, 2018-2023
Figure 31. By Type, U.S. Non-24-hour Sleep-wake Disorder Treatment Revenue Market Share, 2022 VS 2029
Figure 32. By Application, U.S. Non-24-hour Sleep-wake Disorder Treatment Revenue Market Share, 2022 VS 2029
Figure 33. Europe Non-24-hour Sleep-wake Disorder Treatment Revenue, 2018-2029, (US$ Million)
Figure 34. By Company, Europe Non-24-hour Sleep-wake Disorder Treatment Market Share, 2018-2023
Figure 35. By Type, Europe Non-24-hour Sleep-wake Disorder Treatment Revenue Market Share, 2022 VS 2029
Figure 36. By Application, Europe Non-24-hour Sleep-wake Disorder Treatment Revenue Market Share, 2022 VS 2029
Figure 37. China Non-24-hour Sleep-wake Disorder Treatment Revenue, 2018-2029, (US$ Million)
Figure 38. By Company, China Non-24-hour Sleep-wake Disorder Treatment Market Share, 2018-2023
Figure 39. By Type, China Non-24-hour Sleep-wake Disorder Treatment Revenue Market Share, 2022 VS 2029
Figure 40. By Application, China Non-24-hour Sleep-wake Disorder Treatment Revenue Market Share, 2022 VS 2029
Figure 41. Japan Non-24-hour Sleep-wake Disorder Treatment Revenue, 2018-2029, (US$ Million)
Figure 42. By Company, Japan Non-24-hour Sleep-wake Disorder Treatment Market Share, 2018-2023
Figure 43. By Type, Japan Non-24-hour Sleep-wake Disorder Treatment Revenue Market Share, 2022 VS 2029
Figure 44. By Application, Japan Non-24-hour Sleep-wake Disorder Treatment Revenue Market Share, 2022 VS 2029
Figure 45. South Korea Non-24-hour Sleep-wake Disorder Treatment Revenue, 2018-2029, (US$ Million)
Figure 46. By Company, South Korea Non-24-hour Sleep-wake Disorder Treatment Market Share, 2018-2023
Figure 47. By Type, South Korea Non-24-hour Sleep-wake Disorder Treatment Revenue Market Share, 2022 VS 2029
Figure 48. By Application, South Korea Non-24-hour Sleep-wake Disorder Treatment Revenue Market Share, 2022 VS 2029
Figure 49. Southeast Asia Non-24-hour Sleep-wake Disorder Treatment Revenue, 2018-2029, (US$ Million)
Figure 50. By Company, Southeast Asia Non-24-hour Sleep-wake Disorder Treatment Market Share, 2018-2023
Figure 51. By Type, Southeast Asia Non-24-hour Sleep-wake Disorder Treatment Revenue Market Share, 2022 VS 2029
Figure 52. By Application, Southeast Asia Non-24-hour Sleep-wake Disorder Treatment Revenue Market Share, 2022 VS 2029
Figure 53. India Non-24-hour Sleep-wake Disorder Treatment Revenue, 2018-2029, (US$ Million)
Figure 54. By Company, India Non-24-hour Sleep-wake Disorder Treatment Market Share, 2018-2023
Figure 55. By Type, India Non-24-hour Sleep-wake Disorder Treatment Revenue Market Share, 2022 VS 2029
Figure 56. By Application, India Non-24-hour Sleep-wake Disorder Treatment Revenue Market Share, 2022 VS 2029
Figure 57. Middle East & Asia Non-24-hour Sleep-wake Disorder Treatment Revenue, 2018-2029, (US$ Million)
Figure 58. By Company, Middle East & Asia Non-24-hour Sleep-wake Disorder Treatment Market Share, 2018-2023
Figure 59. By Type, Middle East & Asia Non-24-hour Sleep-wake Disorder Treatment Revenue Market Share, 2022 VS 2029
Figure 60. By Application, Middle East & Asia Non-24-hour Sleep-wake Disorder Treatment Revenue Market Share, 2022 VS 2029
Figure 61. Research Methodology
Figure 62. Breakdown of Primary Interviews
Figure 63. Bottom-up Approaches
Figure 64. Top-down Approaches
Research Methodology:
Non-24-hour Sleep-wake Disorder Treatment Market Size Estimation
To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.
Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.
Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.
We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.
Data Source
Secondary Sources
This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.
These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.
On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.
These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|